Short Interest in Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX) Decreases By 90.9%

Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX – Free Report) saw a significant drop in short interest during the month of June. As of June 15th, there was short interest totalling 100 shares, a drop of 90.9% from the May 31st total of 1,100 shares. Approximately 0.0% of the company’s stock are short sold. Based on an […]

Related Keywords

United States ,Phoenix ,Arizona , ,Boothbay Fund Management ,First Trust Capital Management ,Nasdaq ,Meteora Capital ,Phoenix Biotech Acquisition Corp ,Phoenix Biotech Acquisition ,Free Report ,Biotech Acquisition ,Fund Management ,Rock Financial ,Phoenix Biotech Acquisition Daily ,Nasdaq Pbax ,Pbax ,Unclassified ,Stocks ,Options ,Put ,Call ,